M - Laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. In vitro diagnostic (IVD) devices are tests performed on samples taken from the human body, such as swabs of mucus from inside the nose or back of the throat, or blood taken from a vein or fingerstick. The shelf-life is how long the test should work as expected and is measured from the date the test was manufactured. A molecular test detects the genetic material of SARS-CoV-2. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. By, Discover Nature (Missouri Department of Conservation), Innovations in Health Care from the University of Missouri. UPDATE. Individual EUAs will allow for broader indications and scopes of authorization, individualized conditions of authorization to address any issue unique to a specific test, and more streamlined EUA amendments, such as additional uses that would not fall under this umbrella EUA. There are two main types of viral tests: nucleic acid amplification tests (NAATs) and antigen tests. Results are usually available in 30 minutes or less. To see additional authorization documents, such as letters granting EUA amendments or revisions, and a list of other brand names authorized under a specific EUA, select the plus (+) button beside the "Date EUA Issued or Last Updated" for each EUA. Coronavirus (COVID-19) and Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus (COVID-19) and Medical Devices, Counterfeit At-Home OTC COVID-19 Diagnostic Tests, At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions, Blood Specimen Collection Tube Shortage: Frequently Asked Questions, Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers, Emergency Use Authorization of COVID-19 Tests: Independent Assessment of the FDAs Response, Face Masks, Barrier Face Coverings, Surgical Masks, and Respirators for COVID-19, Medical Device Supply Chain Notifications During the COVID-19 Pandemic, Medical Device Shortages During the COVID-19 Public Health Emergency, Supplies of Medical Devices for COVID-19: Frequently Asked Questions, Medical Device Types to Help Determine Section 506J Notification Obligations, Non-contact Temperature Assessment Devices During the COVID-19 Pandemic, Adverse Event Reporting for Medical Devices Under Emergency Use Authorization (EUA) or Discussed in COVID-19-Related Guidance Documents, Contacts for Medical Devices During the COVID-19 Pandemic, COVID-19 Tests and Collection Kits Authorized by the FDA: Infographic, 63 home collection: Tests and collection kits where samples are collected at home and sent to a lab for processing, 32 pooling: Tests that process samples from multiple people at one time, 55 point-of-care: Tests and rapidly return a result at your doctor's office or other health care setting, 19multi-analyte: Tests that detect the virus that causes COVID-19 and other viruses like flu, 13 at-home: Tests performed at home with a self-collected sample, 38 home collection: Tests and collection kits where samples are collected at home and sent to a lab for processing, 18 pooling: Tests that process samples from multiple people at one time, 17 point-of-care: Tests and rapidly return a result at your doctor's office or other health care setting, 11 multi-analyte: Tests that detect the virus that causes COVID-19 and other viruses like flu, 3 at-home: Tests performed at home with a self-collected sample. The templates reflect the FDA's current thinking on the data and information that developers should submit to facilitate the EUA process. This infographic provides a visualization of data about the coronavirus (COVID-19) diagnostic tests authorized by the FDA. On September 23, 2021, the FDA revised the EUAs of certain molecular, antigen, and serology tests to establish additional Conditions of Authorization in response to the continued emergence of new variants of SARS-CoV-2. Understanding COVID-19 tests, including the different types of tests and their uses, and the types of samples the tests use, is key to making an informed decision that meets your needs. Be aware that COVID-19 diagnostic tests are authorized for specific uses and that laboratory-based molecular COVID-19 tests, are generally more accurate than at-home tests. SAN DIEGO Pilot projects launched last year to examine how information warfare gurus can enhance submarine operations may yield long-term plans. Different tests are authorized to be used with different types of samples. Travel . The test is to be performed two times over three days (serial testing). databases. To see if the expiration date for your at-home OTC COVID-19 test has been extended, first find the row in the below table that matches the manufacturer and test name shown on the box label of your test. Be sure to check the At-Home OTC COVID-19 Diagnostic Tests website for information on expiration dates, who can use the test, and other details that may help you decide what test is right for you. In 1947, Salk accepted a professorship at the University of Pittsburgh School of . Since August 9, 2022, the standard regimen has also been authorized for people aged <18 years under . Click here for a full list of FDA approved at-home COVID tests and their up-to-date expiration dates. Antigen multi-analyte respiratory panel tests authorized in the table below are assigned the QMN product code. The most important thing to consider when looking for an updated expiration date is the brand or manufacturer of the at-home COVID test. Below is a list of the 11 tests currently approved by the FDA for use at home: CareStart COVID-19 Antigen Home Test iHealth COVID-19 Antigen Rapid Test BD Veritor At-Home COVID-19. It quickly pivoted to a health professionals-only test and then rereleased its kit to the public after the. People without symptoms. The test is to be performed two times over three days (serial testing). View graphs and map for Testing in U.S. for COVID-19. This revision is effective as of September 23, 2021 for all EUAs that are within the scope of the revision. Cases, data, and surveillance to track and analyze COVID-19. If you think you need a COVID-19 diagnostic test, you can find a community testing site in your state. 3 Abbreviations: CLIA = chemiluminescence immunoassay; ELISA = enzyme-linked immunosorbent assay; ECLIA = electrochemiluminescence immunoassay; FMIA = fluorescent microsphere Immunoassay, CMIA = chemiluminescent microparticle immunoassay; ELFA = enzyme-linked fluorescence assay. Get the best experience and stay connected to your community with our Spectrum News app. More research is needed to determine what, if anything, antibody tests can tell us about a persons immunity. Coronavirus (COVID-19) and Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus (COVID-19) and Medical Devices, Counterfeit At-Home OTC COVID-19 Diagnostic Tests, At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions, Blood Specimen Collection Tube Shortage: Frequently Asked Questions, Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers, Emergency Use Authorization of COVID-19 Tests: Independent Assessment of the FDAs Response, Face Masks, Barrier Face Coverings, Surgical Masks, and Respirators for COVID-19, Medical Device Supply Chain Notifications During the COVID-19 Pandemic, Medical Device Shortages During the COVID-19 Public Health Emergency, Supplies of Medical Devices for COVID-19: Frequently Asked Questions, Medical Device Types to Help Determine Section 506J Notification Obligations, Non-contact Temperature Assessment Devices During the COVID-19 Pandemic, Adverse Event Reporting for Medical Devices Under Emergency Use Authorization (EUA) or Discussed in COVID-19-Related Guidance Documents, Contacts for Medical Devices During the COVID-19 Pandemic, General Information About At-Home OTC COVID-19 Diagnostic Tests, List of Authorized At-Home OTC COVID-19 Diagnostic Tests, In Vitro Diagnostics EUAs: Tables of IVD EUAs, See link for list of updated expiration dates, Cue COVID-19 Test for Home and Over The Counter (OTC) Use, MaximBio ClearDetect COVID-19 Antigen Home Test, link for list of updated expiration dates, INDICAID COVID-19 Rapid Antigen At-Home Test, CLINITEST Rapid COVID-19 Antigen Self-Test, Speedy Swab Rapid COVID-19 Antigen Self-Test, Understanding At-Home OTC COVID-19 Antigen Diagnostic Test Results, At-Home COVID-19 Antigen Tests-Take Steps to Reduce Your Risk of False Negative: FDA Safety Communication, COVID-19 Testing: What You Need to Know | CDC, COVID-19 Self-Testing At-Home or Anywhere | CDC, What to Do If You Were Exposed to COVID-19 | CDC, Isolation and Precautions for People with COVID-19 | CDC. The most common sample types are: Swab samples use a swab (similar to a long Q-Tip) to collect a sample from the nose or throat. People have the option to buy an over-the-counter home COVID-19 test, but experts say they should make sure what they get has been approved by the U.S. Food and Drug Administration. Skip to main content . . This page has information about at-home over-the-counter (OTC) COVID-19 diagnostic tests. Self-tests for COVID-19 give rapid results and can be taken anywhere, regardless of your vaccination status or whether or not you have symptoms. M - Laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. The FDA has determined that establishing additional conditions is necessary to mitigate the potential risk of false negative results due to either decreased sensitivity or non-reactivity associated with SARS-CoV-2 viral mutations. Serology tests could play a role in the fight against COVID-19 by helping healthcare professionals identify individuals who may have developed an immune response to SARS-CoV-2. Antibody tests should not be used to diagnose a current SARS-CoV-2 infection or COVID-19 and, at this time, should also not be used to check for immunity. This test is usually conducted at the point-of-care or a sample is collected and . "This is a huge milestone," Dr. Michael Mina, a Harvard epidemiologist who has been. For more information about how to reduce your risk of getting a false negative result on an at-home COVID-19 antigen test, read our FDA Safety Communication. 8/24/2021. For more information, including answers to frequently asked general questions about at-home COVID-19 diagnostic tests, visit At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions. FDA Advisory No.2021-2094 || List of COVID-19 Test Kits with FDA Special Certification and Performance Validation Conducted and/or Recommended by the Research Institute for Tropical Medicine (RITM) - Food and Drug Administration Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Continuous Renal Replacement Therapy and Hemodialysis Devices EUAs, Remote or Wearable Patient Monitoring Devices EUAs, Ventilators and Ventilator Accessories EUAs, Emergency Use Authorizations for Medical Devices, In Vitro Diagnostics EUAs - Serology and Other Adaptive Immune Response Tests for SARS-CoV-2, Molecular Diagnostic Tests for SARS-CoV-2, Individual EUAs for Serology and Other AdaptiveImmune Response Tests for SARS-CoV-2, Umbrella EUA for Independently Validated Serology Tests for SARS-CoV-2, Historical Information about Device Emergency Use Authorizations: In Vitro Diagnostics (IVD), EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA (IgG), Letter Granting EUA Revision(s) (March 1, 2022), Letter Granting EUA Amendment(s) (May 9, 2020), Letter Granting EUA Amendment(s) (June 22, 2020), Letter Granting EUA Revision(s) (September 18, 2020), Letter Granting EUA Revision(s) (December 1, 2020), Viral Mutation Revision Letter (September 23, 2021), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack, Letter Granting EUA Revision(s) (October 30, 2020), Letter Granting EUA Revision(s) (January 29, 2021), Letter Granting EUA Amendment(s) (July 22, 2020), Letter Granting EUA Revision(s) (October 19, 2020), Letter Granting EUA Revision(s) (October 7, 2021), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack, Letter Granting EUA Revision(s) (May 20, 2020), Letter Granting EUA Revision(s) (October 23, 2020), Letter Granting EUA Amendment(s) (July 21, 2020), Letter Granting EUA Revision(s) (February 25, 2022), New York SARS-CoV Microsphere Immunoassay for Antibody Detection, Letter Granting EUA Amendment(s) (June 4, 2020), Letter Granting EUA Revision(s) (July 13, 2021), COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma), RightSign COVID-19 IgG/IgM Rapid Test Cassette, Letter Granting EUA Amendment(s) (July 23, 2020), Letter Granting EUA Revision(s) (August 31, 2020), Dimension Vista SARS-CoV-2 Total antibody assay (COV2T), Letter Granting EUA Amendment(s) (August 7, 2020), Dimension EXL SARS-CoV-2 Total antibody assay (CV2T), Letter Granting EUA Revision(s) (April 21, 2022), Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit, Letter Granting EUA Amendment(s) (August 3, 2020), Letter Granting EUA Revision(s) (October 17, 2020), LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold), Letter Granting EUA Revision(s) (August 12, 2020), Letter Granting EUA Revision(s) (December 2, 2020), Letter Granting EUA Revision(s) (February 14, 2022), Assure COVID-19 IgG/IgM Rapid Test Device, Letter Granting EUA Revision(s) (January 31, 2022), Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette, Letter Granting EUA Revision(s) (July 12, 2021), Letter Granting EUA Revision(s) (March 9, 2022), BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test, Letter Granting EUA Revision(s) (November 6, 2020), Letter Granting EUA Revision(s) (October 31, 2020), Letter Granting EUA Revision(s) (March 19, 2021), BioCheck SARS-CoV-2 IgG and IgM Combo Test, Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test, Letter Granting EUA Revision(s) (November 2, 2021), Letter Granting EUA Revision(s) (November 19, 2021), BioCheck SARS-CoV-2 IgM Antibody Test Kit, BioCheck SARS-CoV-2 IgG Antibody Test Kit, Letter Granting EUA Revision(s) (November 10, 2020), Letter Granting EUA Revision(s) (November 5, 2021), Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit, OmniPATH COVID-19 Total Antibody ELISA Test, Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2, cPass SARS-CoV-2 Neutralization Antibody Detection Kit, Letter Granting EUA Revision(s) (February 1, 2022), COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit, Letter Granting EUA Revision(s) (May 4, 2021), Letter Granting EUA Revision(s) (February 9, 2022), Letter Granting EUA Revision(s) (August 24, 2022), Innovita 2019-nCoV Ab Test (Colloidal Gold), Letter Granting EUA Revision(s) (June 28, 2021), MidaSpot COVID-19 Antibody Combo Detection Kit, Letter Granting EUA Revision(s) (January 25, 2021), Letter Granting EUA Revision(s) (February 5, 2021), Letter Granting EUA Revision(s) (April 12, 2021), Letter Granting EUA Revision(s) (July 29, 2021), Letter Granting EUA Revision(s) (April 2, 2021), Letter Granting EUA Revision(s) (April 26, 2021), Letter Granting EUA Revision(s) (July 21, 2022), COVID-19 Self-Collected Antibody Test System, Letter Granting EUA Revision(s) (June 24, 2021), ZEUS ELISA SARS-CoV-2 Total Antibody Test System, Letter Granting EUA Revision(s) (February 28, 2022), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Quantitative Reagent Pack used in combination with the VITROS Immunodiagnostic Products Anti- SARS-CoV-2 IgG Quantitative Calibrator, Letter Granting EUA Revisions(s) (September 8, 2021, Letter Granting EUA Revisions(s) (June 29, 2022), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total N Reagent Pack used in combination with the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total N Antibody Calibrators, Letter Granting EUA Revision(s) (August 31, 2022), Diazyme SARS-CoV-2 Neutralizing Antibody CLIA Kit, SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests, IgG, Lateral Flow, Fingerstick Whole Blood, Wadsworth Center, New York State Department of Health, IgM and IgG Lateral Flow, Fingerstick Whole Blood, ThermoGenesis SARS-CoV-2 IgM/IgG Antibody Test Kit, IgM and IgG, Lateral Flow, Fingerstick Whole Blood. But the move came after tests last month showed the masks didn't meet standards. Rapid tests detect protein. W - Patient care settings operating under a CLIA Certificate of Waiver. Authorized EUA devices in the table below for SARS-CoV-2 antigen diagnostic tests are assigned the QKP product code. These EUAs have been issued for each individual test with certain conditions of authorization required of the manufacturer and authorized laboratories. Once you've confirmed your vitamin D levels via testing, adjust your sun exposure and/or vitamin D3 supplementation accordingly. On September 23, 2021, the FDA revised the EUAs of certain molecular, antigen, and serology tests to establish additional Conditions of Authorization in response to the continued emergence of. On November 1, 2022, the FDA revised the authorized uses and required updates to product labeling regarding repeat, or serial, testing, for all currently authorized SARS-CoV-2 antigen tests. These include molecular tests,. A COVID-19 test done with a sample of your blood (serology) only detects if your body has developed antibodies in response to the COVID-19 virus. At-Home COVID-19 Antigen Tests-Take Steps to Reduce Your Risk of False Negative, Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Serial Screening, Single Target, Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Serial Screening, Single Target,Telehealth Proctor Supervised (optional), Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Serial Screening, Multiple Targets, Lateral Flow, Visual Read, Serial Screening, Single Target, Lateral Flow, Digital Read, Over the Counter (OTC) Home Testing, Serial Screening, Single Target, Lateral Flow, Fluorescence, Instrument Read, Serial Screening, Single Target, Chromatographic Digital Immunoassay, Instrument Read, Serial Screening, Single Target, Microfluidic Immunofluorescence Assay, Instrument Read, Serial Screening, Single Target, Lateral Flow, Visual Read, Single Target, Serial Screening, Lateral Flow, Fluorescence, Instrument Read, Multi-Analyte, Single Target, Magnetic Force-assisted Electrochemical Sandwich Immunoassay (MESIA), Single Target, Lateral flow immunoluminescent assay, instrument read, Serial Screening, Single Target, Lateral Flow, Fluorescence, Instrument Read, Over the Counter (OTC) Home Testing, Serial Screening, Single Target, Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Telehealth Proctor Supervised, Serial Screening, Single Target, Chemiluminescence Immunoassay, Instrument Read, Single Target, Lateral Flow, Visual Read, Multi-analyte, Single Target, Lateral Flow, Visual Read, Prescription Home Testing, Single Target, Chromatographic Digital Immunoassay, Instrument Read, Multi-analyte, Single Target, Bulk Acoustic Wave (BAW) Biosensor, Instrument Read, Serial Screening, Single Target, Lateral Flow, Visual Read, Serial Screening, Multiple Targets, Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Serial Screening, Single Target, Lateral Flow, Visual Read, Serial Screening, Single Target, Lateral Flow, Fluorescence, Instrument Read, Single Target, Lateral Flow, Visual Read,Serial Screening, Single Target, Digital Lateral Flow, Fluorescence, Instrument Read, Single Target, Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Serial Testing, Serial Screening, Single Target. The FDA has updated expiration dates for those tests. The Ohio State University Wexner Medical Center. On April 28, 2020, FDA issued an umbrella EUA for SARS-CoV-2 Antibody Tests (Lateral flow or Enzyme-linked immunosorbent assay (ELISA) tests) that have been evaluated in an independent. The Food and Drug Administration prohibited 65 manufacturers from selling masks for medical use. Seagen back in M&A talks after Merck walked away: WSJ Eli Lilly slashes insulin prices by 70%, caps out-of-pocket costs in major access overhaul FDA hands first emergency authorization to over-the-counter test for both COVID and flu Sanofi, poised to rival Roche in hemophilia, nabs FDA approval for Altuviiio BioCryst hits another hurdle, delays . (TB), all tests and examinations for TB diagnosis should be pursued without delay, regardless of JYNNEOS . There are several types of SARS-CoV-2 and COVID-19 related IVDs: The web pages below include tables of SARS-CoV-2 and COVID-19 related IVDs with emergency use authorizations (EUAs). Everlywell was one of the first brands to release its at-home coronavirus test kit. Accordingly, the EUA was revoked under Section 564(g)(2)(C) of the Federal Food, Drug, and Cosmetic (FD&C) Act. These EUAs have been issued for each individual test with certain conditions of authorization required of the manufacturer and authorized laboratories. Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Continuous Renal Replacement Therapy and Hemodialysis Devices EUAs, Remote or Wearable Patient Monitoring Devices EUAs, Ventilators and Ventilator Accessories EUAs, Emergency Use Authorizations for Medical Devices, In Vitro Diagnostics EUAs - Antigen Diagnostic Tests for SARS-CoV-2, Molecular Diagnostic Tests for SARS-CoV-2, Serology and Other Adaptive Immune Response Tests for SARS-CoV-2, Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2, Antigen EUA Revisions for Serial (Repeat) Testing, Historical Information about Device Emergency Use Authorizations: In Vitro Diagnostics (IVD), INDICAID COVID-19 Rapid Antigen At-Home Test, Letter Granting EUA Revision(s) (May 12, 2022), Letter Granting EUA Revision(s) (August 12, 2022), Letter Granting EUA Revision(s) (December 22, 2022), Letter Granting EUA Revision(s) (March 7, 2022), Letter Granting EUA Revision(s) (April 28, 2022), Letter Granting EUA Revision(s) (June 24, 2022), Letter Granting EUA Revision(s) (October 14, 2022), Letter Granting EUA Revision(s) (March 29, 2022), Letter Granting EUA Revision(s) (April 4, 2022), Letter Granting EUA Revision(s) (July 8, 2022), Letter Granting EUA Revision(s) (January 11, 2023), Letter Granting EUA Revision(s) (November 4, 2022), Letter Granting EUA Revision(s) (January 20, 2023), Letter Granting EUA Revision(s) (October 15, 2021), Letter Granting EUA Revision(s) (April 20, 2022), Letter Granting EUA Revision(s) (September 2, 2022), Letter Granting EUA Revision(s) (November 18, 2022), Letter Granting EUA Revision(s) (August 24, 2022), Letter Granting EUA Amendment(s) (June 9, 2020), Letter Granting EUA Amendment(s) (July 17, 2020), Viral MutationRevision Letter - September 23, 2021, BD Veritor System for Rapid Detection of SARS-CoV-2, Letter Granting EUA Amendment(s) (July 23, 2020), Letter Granting EUA Revision(s) (December 10, 2021), Letter Granting EUA Revision(s) (January 26, 2021), Letter Granting EUA Revision(s) (February 17, 2022), Letter Granting EUA Revision(s) (April 6, 2021), Letter Granting EUA Revision(s) (January 7, 2022), Letter Granting EUA Revision(s) (February 4, 2022), Letter Granting EUA Revision(s) (November 21, 2022), Letter Granting EUA Revision(s) (March 15, 2021), Letter Granting EUA Revisions(s) (July 16, 2021), Letter Granting EUA Revision(s) (December 2, 2021), Letter Granting EUA Revision(s) (January 17, 2023), VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Reagent Pack, Letter Granting EUA Revision(s) (November 16, 2021), BD Veritor System for Rapid Detection of SARS-CoV-2 & Flu A+B, Letter Granting EUA Revision(s) (July 21, 2022), Letter Granting EUA Revision(s) (September 23, 2022), Letter Granting EUA Revision(s) (December 21, 2022), Letter Granting EUA Revision(s) (July 12 2021), Letter Granting EUA Revision(s) (February 16, 2022), Letter Granting EUA Revision(s) (October 25, 2022), Celltrion DiaTrust COVID-19 Ag Rapid Test, Letter Granting EUA Revision(s) (August 11, 2022), Letter Granting EUA Revision(s) (March 3, 2022), Letter Granting EUA Revision(s) (May 26, 2022), Letter Granting EUA Revision(s) (December 23, 2022), Sienna-Clarity COVID-19 Antigen Rapid Test Cassette, Letter Granting EUA Revision(s) (December 17, 2021), Letter Granting EUA Revision(s) (June 09, 2022), Letter Granting EUA Revision(s) (August 3, 2022), Letter Granting EUA Revision(s) (February 01, 2023), Letter Granting EUA Revision(s) (June 13, 2022), Letter Granting EUA Revision(s) (February 21, 2023), Letter Granting EUA Revision(s) (January 14, 2022), Letter Granting EUA Revision(s) (February 22, 2022), Letter Granting EUA Revision(s) (December 28, 2022), Letter Granting EUA Revision(s)(August 23, 2021), Letter Granting EUA Revision(s) (January 22, 2022), Letter Granting EUA Revisions(s) (June 7, 2022), Letter Granting EUA Revision(s) (August 29, 2022), Letter Granting EUA Revision(s) (September 28, 2022), Letter Granting EUA Revision(s) (Feburary 1, 2022, CLINITEST Rapid COVID-19 Antigen Self-Test, Letter Granting EUA Revision(s) (June 23, 2022, Letter Granting EUA Revision(s) (October 12, 2022), Letter Granting EUA Revision(s) (December 27, 2022), MaximBio ClearDetect COVID-19 Antigen Home Test, Letter Granting EUA Revision(s) (March 30, 2022), Letter Granting EUA Revision(s) (July 22, 2022), Letter Granting EUA Revision(s) (December 16, 2022), Letter Granting EUA Revision(s) (January 09, 2023), Letter Granting EUA Revision(s) (May 4, 2022), Letter Granting EUA Revision(s) (December 2, 2022), Letter Graning EUA Revision(s) (February 24, 2023), ADVIA Centaur SARS-CoV-2 Antigen (CoV2Ag), Letter Granting EUA Revision(s) (August 19, 2022), Letter Granting EUA Revision(s) (October 18, 2022), Speedy Swab Rapid COVID-19 Antigen Self-Test, Letter Granting EUA Revision(s) (August 23, 2022).
By Learning The Language Of The River, The Speaker Gains,
Articles L